Innovative approach for self-management and social welfare of children with cystic fibrosis in Europe: development, validation and implementation of an mHealth tool (MyCyFAPP)
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Introduction: For the optimal management of children with cystic fibrosis, there are currently no efficient tools for the precise adjustment of pancreatic enzyme replacement therapy, either for advice on appropriate dietary intake or for achieving an optimal nutrition status. Therefore, we aim to develop a mobile application that ensures a successful nutritional therapy in children with cystic fibrosis. Methods and analysis: A multidisciplinary team of 12 partners coordinate their efforts in 9 work packages that cover the entire so-called ‘from laboratory to market’ approach by means of an original and innovative co-design process. A cohort of 200 patients with cystic fibrosis aged 1–17 years are enrolled. We will develop an innovative, clinically tested mobile health application for patients and health professionals involved in cystic fibrosis management. The mobile application integrates the research knowledge and innovative tools for maximising self-management with the aim of leading to a better nutritional status, quality of life and disease prognosis. Bringing together different and complementary areas of knowledge is fundamental for tackling complex challenges in disease treatment, such as optimal nutrition and pancreatic enzyme replacement therapy in cystic fibrosis. Patients are expected to benefit the most from the outcomes of this innovative project. Ethics and dissemination: The project is approved by the Ethics Committee of the coordinating organisation, Hospital Universitari La Fe (Ref: 2014/0484). Scientific findings will be disseminated via journals and conferences addressed to clinicians, food scientists, information and communications technology experts and patients. The specific dissemination working group within the project will address the wide audience communication through the website ( http://www.mycyfapp.eu ), the social networks and the newsletter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Factors associated with FEV1decline in cystic fibrosis: analysis of the ECFS Patient Registry
Kerem, E., Viviani, L., Zolin, A., MacNeill, S., Hatziagorou, E., Ellemunter, H., Drevinek, P., Gulmans, V., Krivec, U., & Olesen, H. (2014) · European Respiratory Journal · doi:10.1183/09031936.00166412 · Cited by 296
Studies on effects of dietary fatty acids as related to their position on triglycerides
Hunter, J. E. (2001) · Lipids · doi:10.1007/s11745-001-0770-0 · Cited by 257 · cited 1×
“In addition, pancreatic lipase exhibits different hydrolytic activity depending on the intramolecular structure of the lipids.(14) 18 19 Therefore, lipolysis may cause different kinetics of release of absorbable fatty acids.”
Background
Research works printed but not linked: 19
- Colombo, 2011, The implementation of standards of care in Europe: state of the art, J Cyst Fibros, 10, S7, 10.1016/S1569-1993(11)60003-9 · DOI
- 10.1038/ejcn.2013.20 · DOI
- 10.3945/ajcn.112.051409 · DOI · Paper page
- Fieker, 2011, Enzyme replacement therapy for pancreatic insufficiency: present and future, Clin Experiment Gastroenterol, 4, 55
- 10.1016/j.bpg.2010.03.006 · doi:10.1016/j.bpg.2010.03.006
- 10.1136/gut.2004.062786 · DOI · Paper page
- Woestenenk, 2015, Pancreatic enzyme replacement therapy and coefficient of fat absorption in children and adolescents with cystic fibrosis, J Pediatr Gastroenterol Nutr, 61, 355, 10.1097/MPG.0000000000000784 · DOI
- Haupt, 2014, Pancreatic enzyme replacement therapy dosing and nutritional outcomes in children with cystic fibrosis, J Pediatr, 164, 1110, 10.1016/j.jpeds.2014.01.022 · DOI
- 10.1097/01.mpg.0000178439.64675.8d · DOI
- 10.1016/j.jcf.2013.05.011 · doi:10.1016/j.jcf.2013.05.011
- Turck, 2016, ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis, Clin Nutr, 35, 557, 10.1016/j.clnu.2016.03.004 · DOI · Paper page
- Li, 2011, Factors affecting lipase digestibility of emulsified lipids using an in vitro digestion model: proposal for a standardised pH-stat method, Food Chem, 126, 498, 10.1016/j.foodchem.2010.11.027 · DOI · Paper page
- Stuknytė, 2015, Occurrence and fate of ACE-inhibitor peptides in cheeses and in their digestates following in vitro static gastrointestinal digestion, Food Chem, 168, 27, 10.1016/j.foodchem.2014.07.045 · DOI
- 10.1111/j.1750-3841.2007.00274.x · DOI · Paper page
- 10.1016/j.plipres.2008.12.001 · DOI · Paper page
- Zhu, 2013, Free fatty acid profiles of emulsified lipids during in vitro digestion with pancreatic lipase, Food Chem, 139, 398, 10.1016/j.foodchem.2012.12.060 · DOI
- Lesmes, 2012, Controlling lipid digestibility: response of lipid droplets coated by β-lactoglobulin-dextran Maillard conjugates to simulated gastrointestinal conditions, Food Hydrocolloids, 26, 221, 10.1016/j.foodhyd.2011.05.011 · DOI
- Giang, 2016, Dynamic modeling of in vitro lipid digestion: individual fatty acid release and bioaccessibility kinetics, Food Chem, 194, 1180, 10.1016/j.foodchem.2015.08.125 · DOI
- Nieva-Echevarría, 2016, A study by 1H NMR on the influence of some factors affecting lipid in vitro digestion, Food Chem, 211, 17, 10.1016/j.foodchem.2016.05.021 · DOI
Cited by
Therapies for rare diseases: therapeutic modalities, progress and challenges ahead
Tambuyzer, E., Vandendriessche, B., Austin, C. P., Brooks, P. J., Larsson, K., Miller Needleman, K. I., Valentine, J., Davies, K., Groft, S. C., Preti, R., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0049-9 · Cited by 357
Calthorpe, R. J., Smith, S., Gathercole, K., & Smyth, A. R. (2020) · Thorax · doi:10.1136/thoraxjnl-2019-213233 · Cited by 61
Aboye, G. T., Vande Walle, M., Simegn, G. L., & Aerts, J.-M. (2023) · Digital Health · doi:10.1177/20552076231180972 · Cited by 31
Calvo-Lerma, J., Boon, M., Hulst, J., Colombo, C., Asseiceira, I., Garriga, M., Masip, E., Claes, I., Bulfamante, A., Janssens, H. M., et al. (2021) · Nutrients · doi:10.3390/nu13061801 · Cited by 14
Self-citation
Metadata
- Authors
- Calvo-Lerma, J., Martinez-Jimenez, C. P., Lázaro-Ramos, J.-P., Andrés, A., Crespo-Escobar, P., Stav, E., Schauber, C., Pannese, L., Hulst, J. M., Suárez, L., Colombo, C., Barreto, C., de Boeck, K., & Ribes-Koninckx, C.
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2017-03
- Volume
- 7
- Issue
- 3
- Pages
- e014931
- ISSN
- 2044-6055 (ISSN-L)
- OpenAlex
- W2595836823
- Cited by
- 34
- References
- 2
- FWCI
- 9.51
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Horizon 2020 (643806)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Innovative approach for self-management and social welfare of children with cystic fibrosis in Europe: development, validation and implementation of an mHealth tool (MyCyFAPP). https://app.cochat.ai/papers/10.1136/bmjopen-2016-014931
- The paper
- Calvo-Lerma, J., Martinez-Jimenez, C. P., Lázaro-Ramos, J.-P., Andrés, A., Crespo-Escobar, P., Stav, E., Schauber, C., Pannese, L., Hulst, J. M., Suárez, L., Colombo, C., Barreto, C., de Boeck, K., & Ribes-Koninckx, C. (2017). Innovative approach for self-management and social welfare of children with cystic fibrosis in Europe: development, validation and implementation of an mHealth tool (MyCyFAPP). BMJ Open. https://doi.org/10.1136/bmjopen-2016-014931
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.